BioSpace News Archive

Atreca, Inc. (Atreca) (NASDAQ: BCEL), today announced that it will present data on broadly neutralizing SARS-CoV-2 antibodies discovered by the company at the upcoming Keystone Symposia Conference: Antibodies as Drugs, being held January 30 – February 2, 2022 both in Keystone, Colo. and virtually.

Aadi Bioscience, Inc. (“Aadi”), a biopharmaceutical company focusing on precision therapies for genetically-defined cancers with alterations in mTOR pathway genes, today announced that Founder, Chief Executive Officer and President, Neil Desai, Ph.D., will present at the H.C. Wainwright BioConnect Conference, to be held virtually January 10-13, 2022.

Disc Medicine announced the appointment of Jay T. Backstrom, M.D., M.P.H., to its Board of Directors, and the appointment of Rahul Khara, Pharm.D., J.D., as General Counsel.

Labcorp (NYSE: LH), a leading global life sciences company, today announced that members of the executive management team will participate in a virtual fireside chat at the 40th Annual J.P. Morgan Healthcare Conference on Tuesday, Jan. 11 at 4:30 p.m. (ET).

Abbott will announce its fourth-quarter 2021 financial results on Wednesday, Jan. 26, 2022, before the market opens.

908 Devices and the United States Forest Service (USFS), an agency of the United States Department of Agriculture (USDA), are collaborating on a research effort to extend the capabilities of the MX908 handheld device for rapid detection of toxic pesticides used in illegal marijuana grows on federal lands.

Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that Robert M. Davis, chief executive officer and president, Dr. Dean Y. Li, president, Merck Research Laboratories, are scheduled to virtually participate in the 40th Annual J.P. Morgan Healthcare Conference on Jan. 10, 2022 at 5:15 p.m. ET.

DreamTec Research Limited (DreamTec, http://www.dreamtec.hk) has its major breakthrough in developing a COVID-19 oral vaccine.

Antengene Corporation Limited announced that management from Antengene will be participating in the 40th Annual J.P. Morgan Healthcare Conference in January 2022.